Cargando…

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

BACKGROUND: There is limited evidence on the optimal timing of antiretroviral therapy (ART) initiation in children 2–5 y of age. We conducted a causal modelling analysis using the International Epidemiologic Databases to Evaluate AIDS–Southern Africa (IeDEA-SA) collaborative dataset to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schomaker, Michael, Egger, Matthias, Ndirangu, James, Phiri, Sam, Moultrie, Harry, Technau, Karl, Cox, Vivian, Giddy, Janet, Chimbetete, Cleophas, Wood, Robin, Gsponer, Thomas, Bolton Moore, Carolyn, Rabie, Helena, Eley, Brian, Muhe, Lulu, Penazzato, Martina, Essajee, Shaffiq, Keiser, Olivia, Davies, Mary-Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833834/ https://www.ncbi.nlm.nih.gov/pubmed/24260029 http://dx.doi.org/10.1371/journal.pmed.1001555

Ejemplares similares

Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration
por: Davies, Mary-Ann, et al.
Publicado: (2013)

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations
por: Doherty, Kathleen, et al.
Publicado: (2014)

Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
por: Johnson, Leigh F., et al.
Publicado: (2013)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission
por: Nyakato, Patience, et al.
Publicado: (2020)

Profile of elderly patients receiving antiretroviral therapy at Newlands Clinic in 2020: A cross-sectional study
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2018)

A case report of untreatable HIV infection in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2019)

Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study
por: Cornell, Morna, et al.
Publicado: (2012)

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
por: Shawarira-Bote, Sandra, et al.
Publicado: (2019)

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
por: Boulle, Andrew, et al.
Publicado: (2014)

Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
por: Bohlius, Julia, et al.
Publicado: (2012)

Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study
por: Shamu, Tinei, et al.
Publicado: (2021)

High Unreported Mortality in Children and Youth (<25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study
por: Nyakato, Patience, et al.
Publicado: (2022)

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy
por: Yiannoutsos, Constantin Theodore, et al.
Publicado: (2012)

Reducing mortality in HIV-infected infants and achieving the 90–90–90 target through innovative diagnosis approaches
por: Essajee, Shaffiq, et al.
Publicado: (2015)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

HIV Testing for Children in Resource-Limited Settings: What Are We Waiting For?
por: Kellerman, Scott, et al.
Publicado: (2010)

Getting back on track to ending AIDS in children: it could just be easier than you think
por: Essajee, Shaffiq, et al.
Publicado: (2023)

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes
por: Ballif, Marie, et al.
Publicado: (2018)

Optimizing drugs to reach treatment targets for children and adolescents living with HIV
por: Penazzato, Martina, et al.
Publicado: (2015)

A Global Research Agenda for Pediatric HIV
por: Penazzato, Martina, et al.
Publicado: (2018)

Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review
por: Mugglin, Catrina, et al.
Publicado: (2013)

Monitoring Virologic Responses to Antiretroviral Therapy in HIV-Infected Adults in Kenya: Evaluation of a Low-Cost Viral Load Assay
por: Sivapalasingam, Sumathi, et al.
Publicado: (2009)

Comparison of predictors for early and late mortality in adults commencing HIV antiretroviral therapy in Zimbabwe: a retrospective cohort study
por: Byers, Bradley W., et al.
Publicado: (2022)

Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study
por: Mudzviti, Tinashe, et al.
Publicado: (2019)

Characterizing the double‐sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa
por: Tsondai, Priscilla R, et al.
Publicado: (2020)

Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration
por: Morden, Erna, et al.
Publicado: (2016)

Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi
por: Feldacker, Caryl, et al.
Publicado: (2012)

Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
por: Estill, Janne, et al.
Publicado: (2013)

Cancer incidence among people living with HIV in Zimbabwe: A record linkage study
por: Shamu, Tinei, et al.
Publicado: (2021)

Editorial Commentary: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care
por: Ford, Nathan, et al.
Publicado: (2015)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis
por: Chihota, Belinda V., et al.
Publicado: (2022)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018)

Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe
por: McCarthy, Elizabeth, et al.
Publicado: (2017)

Safety of Tenofovir Disoproxil Fumarate–Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis
por: Nachega, Jean B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pma19m2bbfi8hk9c1r6q44rv3m